Daphnetin (7,8-dihydroxycoumarin) is a natural coumarin derivative extracted from Daphne genkwa that has demonstrated neuroprotective properties in amyloid-beta (Aβ)-induced Alzheimer's disease (AD) models. Recent research has revealed that daphnetin's therapeutic effects are mediated through restoration of the KCC2 chloride transporter, a critical mechanism for maintaining neuronal chloride homeostasis and proper GABAergic signaling [(Zhou et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/41717267/).
This mechanism page details the role of KCC2 dysfunction in AD pathogenesis and how daphnetin restores chloride homeostasis to ameliorate cognitive deficits.
KCC2 (encoded by the [SLC12A5](/genes/slc12a5) gene) is a potassium-chloride cotransporter predominantly expressed in central nervous system neurons. It functions as an electroneutral transporter that exports chloride ions (Cl⁻) from neurons in exchange for potassium (K⁺) and water. This activity is essential for maintaining the low intracellular chloride concentration required for hyperpolarizing GABA-A receptor responses [(Porcher et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/41230097/) [(Arosio & Musio, 2025)](https://pubmed.ncbi.nlm.nih.gov/41010403/).
Daphnetin (7,8-dihydroxycoumarin) is a natural coumarin derivative extracted from Daphne genkwa that has demonstrated neuroprotective properties in amyloid-beta (Aβ)-induced Alzheimer's disease (AD) models. Recent research has revealed that daphnetin's therapeutic effects are mediated through restoration of the KCC2 chloride transporter, a critical mechanism for maintaining neuronal chloride homeostasis and proper GABAergic signaling [(Zhou et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/41717267/).
This mechanism page details the role of KCC2 dysfunction in AD pathogenesis and how daphnetin restores chloride homeostasis to ameliorate cognitive deficits.
KCC2 (encoded by the [SLC12A5](/genes/slc12a5) gene) is a potassium-chloride cotransporter predominantly expressed in central nervous system neurons. It functions as an electroneutral transporter that exports chloride ions (Cl⁻) from neurons in exchange for potassium (K⁺) and water. This activity is essential for maintaining the low intracellular chloride concentration required for hyperpolarizing GABA-A receptor responses [(Porcher et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/41230097/) [(Arosio & Musio, 2025)](https://pubmed.ncbi.nlm.nih.gov/41010403/).
The transporter operates as a symporter, moving one K⁺ ion and one Cl⁻ ion out of the neuron for each cycle. This creates a steep chloride gradient with intracellular Cl⁻ concentrations approximately 10-20 mM in mature neurons, compared to extracellular levels around 130 mM.
In healthy adult neurons, KCC2 serves several critical functions [(Kim & Martina, 2024)](https://pubmed.ncbi.nlm.nih.gov/38276272/) [(Kreis et al., 2023)](https://pubmed.ncbi.nlm.nih.gov/37168681/):
In Alzheimer's disease, multiple pathological processes impair KCC2 function [(Capsoni et al., 2022)](https://pubmed.ncbi.nlm.nih.gov/35741668/) [(Lam et al., 2022)](https://pubmed.ncbi.nlm.nih.gov/35458638/):
Aβ oligomers directly interact with neuronal membranes and disrupt ion transporter function. Studies have demonstrated that Aβ exposure leads to [(Bie et al., 2022)](https://pubmed.ncbi.nlm.nih.gov/35041847/):
The oxidative stress environment in AD brains affects KCC2 through [(Zhang et al., 2024)](https://pubmed.ncbi.nlm.nih.gov/38819094/):
Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) suppress KCC2 expression through transcriptional mechanisms, creating a feed-forward loop between neuroinflammation and impaired inhibition [(Gao et al., 2022)](https://pubmed.ncbi.nlm.nih.gov/35452800/).
When KCC2 function is compromised, chloride homeostasis is disrupted:
Key consequences include:
| Effect | Mechanism | Result |
|--------|-----------|--------|
| GABA polarity reversal | down Cl- gradient | Excitatory GABA signaling |
| Disinhibition | Loss of inhibitory control | Network hyperexcitability |
| Calcium dysregulation | Depolarization-induced Ca2+ influx | Excitotoxic cell death |
| Epileptiform activity | Synchronized hyperexcitability | Seizure susceptibility |
| Memory impairment | Circuit instability | Cognitive deficits |
The loss of KCC2 function contributes to the broader excitatory-inhibitory (E/I) imbalance observed in AD [(Keramidis et al., 2023)](https://pubmed.ncbi.nlm.nih.gov/37551444/) [(Lam et al., 2023)](https://pubmed.ncbi.nlm.nih.gov/36771011/). This imbalance manifests as:
Daphnetin is a coumarin derivative with the chemical formula C₉H₆O₄. It possesses two hydroxyl groups at positions 7 and 8, conferring antioxidant properties. The compound is lipophilic and can cross the blood-brain barrier.
The primary mechanism by which daphnetin ameliorates Aβ-induced AD is through restoration of KCC2 function [(Zhou et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/41717267/) [(Zhang et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/40237044/):
Evidence suggests daphnetin may directly enhance KCC2 [(Wang et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/41046686/):
Daphnetin also protects KCC2 through [(Yan et al., 2022)](https://pubmed.ncbi.nlm.nih.gov/35657168/) [(Gao et al., 2022)](https://pubmed.ncbi.nlm.nih.gov/35452800/):
Beyond KCC2 restoration, daphnetin exerts additional beneficial effects [(Zhang et al., 2024)](https://pubmed.ncbi.nlm.nih.gov/38819094/) [(Pasandideh & Arasteh, 2021)](https://pubmed.ncbi.nlm.nih.gov/33848544/) [(Pruccoli et al., 2020)](https://pubmed.ncbi.nlm.nih.gov/32630394/):
| Target | Effect | Outcome |
|--------|--------|---------|
| Acetylcholinesterase | Inhibition | Increased synaptic acetylcholine |
| Free radicals | Scavenging | Reduced oxidative damage |
| Pro-inflammatory cytokines | Suppression | Decreased neuroinflammation |
| KCC2 | Restoration | Normalized chloride homeostasis |
The pivotal study demonstrating daphnetin's efficacy used an Aβ₁₋₄₂ injection mouse model [(Zhou et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/41717267/):
Behavioral improvements:
Targeting KCC2 restoration offers several advantages [(Porcher et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/41230097/) [(Yu et al., 2026)](https://pubmed.ncbi.nlm.nih.gov/41810694/) [(Yu et al., 2025)](https://pubmed.ncbi.nlm.nih.gov/40950140/):
Potential therapeutic strategies include [(Tang, 2019)](https://pubmed.ncbi.nlm.nih.gov/31174368/) [(Menzikov et al., 2021)](https://pubmed.ncbi.nlm.nih.gov/33535681/):
Related mechanisms and entities: